These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

248 related articles for article (PubMed ID: 35311434)

  • 1. Advances in pharmacotherapy for acute and recurrent pericarditis.
    Vecchié A; Del Buono MG; Mauro AG; Cremer PC; Imazio M; Klein AL; Abbate A; Dentali F; Bonaventura A
    Expert Opin Pharmacother; 2022 Apr; 23(6):681-691. PubMed ID: 35311434
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Novel Pathophysiological, Diagnostic and Therapeutic Concepts in Acute and Recurrent Pericarditis.
    Bonaventura A; Thomas GK; Golino M; Mauro AG; Vecchié A; Del Buono MG; Toldo S; Potere N; Abbate A
    Rev Cardiovasc Med; 2023 Mar; 24(3):77. PubMed ID: 39077487
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interleukin-1 and the NLRP3 Inflammasome in Pericardial Disease.
    Vecchié A; Del Buono MG; Chiabrando GJ; Dentali F; Abbate A; Bonaventura A
    Curr Cardiol Rep; 2021 Oct; 23(11):157. PubMed ID: 34599390
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interleukin-1 and the Inflammasome as Therapeutic Targets in Cardiovascular Disease.
    Abbate A; Toldo S; Marchetti C; Kron J; Van Tassell BW; Dinarello CA
    Circ Res; 2020 Apr; 126(9):1260-1280. PubMed ID: 32324502
    [TBL] [Abstract][Full Text] [Related]  

  • 5. IL-1 blockade in cardiovascular disease: an appraisal of the evidence across different inflammatory paradigms.
    Bonaventura A; Moroni F; Golino M; Del Buono MG; Vecchié A; Potere N; Abbate A
    Minerva Cardiol Angiol; 2024 Oct; 72(5):477-488. PubMed ID: 37705370
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The autoinflammatory side of recurrent pericarditis: Enlightening the pathogenesis for a more rational treatment.
    Lopalco G; Rigante D; Cantarini L; Imazio M; Lopalco A; Emmi G; Venerito V; Fornaro M; Frediani B; Nivuori M; Brucato A; Iannone F
    Trends Cardiovasc Med; 2021 Jul; 31(5):265-274. PubMed ID: 32376492
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The inflammasome as a therapeutic target for myopericardial diseases.
    Imazio M; Abbate A
    Minerva Cardiol Angiol; 2022 Apr; 70(2):238-247. PubMed ID: 35412034
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An update on the pathophysiology of acute and recurrent pericarditis.
    Bonaventura A; Vecchié A; Mauro AG; Brucato AL; Imazio M; Abbate A
    Panminerva Med; 2021 Sep; 63(3):249-260. PubMed ID: 33337127
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recurrent pericarditis: an update on diagnosis and management.
    Vecchiè A; Dell M; Mbualungu J; Ho AC; VAN Tassell B; Abbate A
    Panminerva Med; 2021 Sep; 63(3):261-269. PubMed ID: 33618510
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Failure of anti Interleukin-1 β monoclonal antibody in the treatment of recurrent pericarditis in two children.
    Signa S; D'Alessandro M; Consolini R; Miniaci A; Bustaffa M; Longo C; Tosca MA; Bizzi M; Caorsi R; Mendonça LO; Pession A; Ravelli A; Gattorno M
    Pediatr Rheumatol Online J; 2020 Jun; 18(1):51. PubMed ID: 32546242
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recurrent Pericarditis: a Stubborn Opponent Meets New Treatments in 2022.
    Hagerty T; Kluge MA; LeWinter MM
    Curr Cardiol Rep; 2022 Aug; 24(8):915-923. PubMed ID: 35612721
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interleukin-1 Blockers for the Treatment of Recurrent Pericarditis: Pathophysiology, Patient-Reported Outcomes, and Perspectives.
    Thomas GK; Bonaventura A; Vecchié A; van Tassell B; Imazio M; Klein A; Luis SA; Abbate A
    J Cardiovasc Pharmacol; 2024 Jun; 83(6):503-510. PubMed ID: 37163222
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anti-interleukin-1 agents for pericarditis: a primer for cardiologists.
    Imazio M; Lazaros G; Gattorno M; LeWinter M; Abbate A; Brucato A; Klein A
    Eur Heart J; 2022 Aug; 43(31):2946-2957. PubMed ID: 34528670
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Current treatment of recurrent pericarditis: safety considerations and future directions.
    Imazio M
    Expert Opin Drug Saf; 2022 Feb; 21(2):183-190. PubMed ID: 34334059
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Colchicine for COVID-19: targeting NLRP3 inflammasome to blunt hyperinflammation.
    Bonaventura A; Vecchié A; Dagna L; Tangianu F; Abbate A; Dentali F
    Inflamm Res; 2022 Mar; 71(3):293-307. PubMed ID: 35113170
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rilonacept and Other Interleukin-1 Inhibitors in the Treatment of Recurrent Pericarditis.
    Goel A; Bandyopadhyay D; Malik AH; Gupta R; Frishman WH; Aronow WS
    Cardiol Rev; 2023 Jul-Aug 01; 31(4):225-229. PubMed ID: 36398320
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Role of NLRP3 Inflammasome in Pericarditis: Potential for Therapeutic Approaches.
    Mauro AG; Bonaventura A; Vecchié A; Mezzaroma E; Carbone S; Narayan P; Potere N; Cannatà A; Paolini JF; Bussani R; Montecucco F; Sinagra G; Van Tassel BW; Abbate A; Toldo S
    JACC Basic Transl Sci; 2021 Feb; 6(2):137-150. PubMed ID: 33665514
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transition to rilonacept monotherapy from oral therapies in patients with recurrent pericarditis.
    Brucato A; Wheeler A; Luis SA; Abbate A; Cremer PC; Zou L; Insalaco A; Lewinter M; Lewis BS; Lin D; Nicholls S; Pancrazi M; Klein AL; Imazio M; Paolini JF
    Heart; 2023 Jan; 109(4):297-304. PubMed ID: 36316102
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rilonacept for the treatment of recurrent pericarditis.
    Fava AM; Reyaldeen R; Lo Presti S; Goyal A; Akintoye E; Hughes D; Klein AL
    Expert Opin Biol Ther; 2022 Jan; 22(1):7-16. PubMed ID: 34757872
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacologic treatment of acute and recurrent pericarditis: a systematic review and meta-analysis of controlled clinical trials.
    Avondo S; Andreis A; Casula M; Biondi-Zoccai G; Imazio M
    Panminerva Med; 2021 Sep; 63(3):314-323. PubMed ID: 34738773
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.